Results 61 to 70 of about 9,502 (222)

Soticlestat as an adjunctive therapy in children and young adults with Dravet syndrome

open access: yesEpilepsia, Volume 67, Issue 6, Page 2796-2807, June 2026.
Overview of the phase 3 trial evaluating soticlestat as adjunctive therapy in children and young adults with Dravet syndrome. Abstract Objective This study evaluated the efficacy, safety, and tolerability of soticlestat as adjunctive therapy in children and young adults with Dravet syndrome (DS).
Joseph Sullivan   +14 more
wiley   +1 more source

Effectiveness of a Combination of Nasturtium Herb and Horseradish Root (Angocin® Anti-Infekt N) Compared to Antibiotics in Managing Acute and Recurrent Urinary Tract Infections: A Retrospective Real-world Cohort Study

open access: yesAntibiotics
Background: The goal of this study was to evaluate whether the medical recommendation of Angocin® Anti-Infekt N, compared to standard antibiotic treatment shortly after the diagnosis of a urinary tract infection (UTI) or cystitis, is negatively ...
Nina Kassner   +5 more
doaj   +1 more source

Mental health impacts experienced by caregivers of people with Dravet syndrome: A systematic literature review

open access: yesEpilepsia, Volume 67, Issue 6, Page 3082-3107, June 2026.
Graphical abstract for the systematic literature review. Abstract Objective Dravet syndrome (DS) places tremendous burden on caregivers owing to the extent of required assistance and impact on daily living, as well as the risk to the individual with DS of premature mortality from sudden unexpected death in epilepsy and morbidity associated with ...
Adam Strzelczyk   +8 more
wiley   +1 more source

Allergic Rhinitis and Its Impact on Asthma (ARIA)‐EAACI Guidelines—2024–2025 Revision: Part II—Guidelines on Oral and Ocular Treatments

open access: yesAllergy, Volume 81, Issue 6, Page 1947-1970, June 2026.
ABSTRACT Background Oral and ocular medications are frequently used in the treatment of allergic rhinitis (AR). As part of the update of the Allergic Rhinitis and its Impact on Asthma (ARIA)‐EAACI guidelines, this manuscript presents the ARIA‐EAACI 2024–2025 recommendations for oral and ocular treatments.
Rafael José Vieira   +230 more
wiley   +1 more source

Arzneimittel-assoziierte Angioödeme: Bradykinin im Fokus

open access: yes, 2017
Das Auftreten von Angioödemen unter Therapie mit ACE-Hemmern ist bekannt und wird auf einen verminderten Bradykininabbau zurückgeführt. Auch für andere Arzneimittel wurde über ein erhöhtes Angioödemrisiko bei alleiniger Anwendung oder in Kombination mit ...
Sachs, Bernhardt, Meier, Tanya
core   +1 more source

Significant Reduction of Body Odor in Older People with a pH 4.0 Emulsion

open access: yesCosmetics, 2015
The impact of increasing age on body odor has become an important issue as our understanding of underlying skin changes in older people has increased.
Michael Kemper   +4 more
doaj   +1 more source

Pharmakovigilanz pflanzlicher Arzneimittel – Stellenwert der Spontanberichterfassung

open access: yes, 2019
Die Sicherheit und Unbedenklichkeit pflanzlicher Arzneimittel in Deutschland waren das Thema einer Masterarbeit im Studiengang Arzneimittelforschung an der Universität Bonn.
Römisch, C., Knöss, W.
core   +1 more source

Sex-specific cortical, hippocampal and thalamic whole genome transcriptome data from controls and a G72 schizophrenia mouse model

open access: yesBMC Research Notes
Objectives The G72 mouse model of schizophrenia represents a well-known model that was generated to meet the main translational criteria of isomorphism, homology and predictability of schizophrenia to a maximum extent.
Anna Papazoglou   +10 more
doaj   +1 more source

Skin pH in the Elderly and Appropriate Skin Care [PDF]

open access: yesEuropean Medical Journal Dermatology, 2013
The acidic skin surface pH (pHSS) plays a crucial role in the maintenance of a vital stratum corneum (SC) and an intact epidermal barrier. However, ageing affects the pH of the skin, both pHSS and the pH of the stratum corneum (pHSC).
Stephan Schreml   +2 more
doaj  

Aseptische Herstellung steriler Arzneimittel

open access: yes, 2022
Wenn eine terminale Sterilisation nicht möglich ist, werden sterile Arzneimittel unter aseptischen Bedingungen hergestellt. Hierbei werden zum Schutz des Produkts vielfältige Maßnahmen zur Kontaminationskontrolle kombiniert.
Schmid, Andreas (Prof. Dr.)
core  

Home - About - Disclaimer - Privacy